Wegovy Maintenance Dosing: What The Evidence Shows
Do You Lose Weight On Maintenance Dose Of Wegovy After Switching?
When patients switch to Wegovy's maintenance dose, clinical evidence suggests continued weight management support is achievable. The STEP trials demonstrated that participants maintained significant weight loss during the 2.4mg maintenance phase, with STEP 5 showing ~15.2% sustained weight loss at 2 years. However, switching from Mounjaro or Ozempic requires careful consideration of dose equivalents and individual response patterns. Your prescriber can guide this transition, as the maintenance effects may vary during the initial switch period.
EverydayMeds specialises in GLP-1 medication switches, providing both Wegovy and alternative treatments through our GPhC-registered pharmacy (#9012878). We understand that patients switch for various reasons including cost management, side effect profiles, or medication availability. Our clinical team ensures you receive appropriate guidance during this transition, helping you understand whether continued weight loss on Wegovy maintenance dose aligns with your individual treatment goals.
Wegovy Maintenance Pricing: Switch & Save Comparison
Switching to Wegovy maintenance can offer significant cost advantages compared to other GLP-1 medications. Our 2.4mg maintenance dose costs £209.99 per pen using discount codes at checkout, with our Consistency 2.4mg bundle (×2 pens) priced at £419.99 for extended supply security. New customers benefit from code FIRST40, while returning patients use DOSE25 to access these competitive rates. The Ultimate Stability Trio provides three months of maintenance supply for £649.99, offering treatment continuity without repeated ordering.
Cost comparison becomes particularly relevant when switching from higher-priced alternatives, as Wegovy maintenance dosing may provide better value for sustained treatment. Our transparent pricing eliminates surprise costs, and the same-pharmacy approach means no registration delays or prescription transfer complications. This financial predictability supports long-term treatment adherence, which clinical evidence shows is crucial for maintaining weight management benefits on any GLP-1 medication maintenance regimen.
Clinical Evidence: Do You Continue Losing Weight On Wegovy Maintenance?
The STEP clinical programme provides robust evidence about weight outcomes during Wegovy maintenance dosing. STEP 1 demonstrated that participants maintained ~15% average weight loss at 68 weeks, with many achieving this during the 2.4mg maintenance phase. STEP 5 extended this timeframe, showing sustained benefits at 2 years when treatment continued alongside lifestyle modifications.
Importantly, the STEP 1 extension study revealed that patients regained approximately two-thirds of lost weight within one year of stopping treatment, emphasising that maintenance dosing serves a critical role in sustained weight management. This evidence supports the concept that Wegovy maintenance can continue supporting weight goals, though individual responses vary and treatment should be viewed as a long-term commitment rather than a short-term intervention.
How Wegovy Maintenance Dose Works For Sustained Weight Management
Wegovy's 2.4mg maintenance dose functions as a GLP-1 receptor agonist, mimicking the natural hormone GLP-1 that regulates appetite and satiety signals. This mechanism continues operating during maintenance treatment, helping patients maintain reduced appetite and increased feelings of fullness after smaller meals. The once-weekly injection provides consistent medication levels, supporting ongoing appetite regulation that many patients find beneficial for long-term weight management. Unlike initial dose escalation phases, maintenance dosing focuses on sustaining achieved benefits rather than promoting additional weight loss. Clinical evidence suggests this approach can be effective when combined with continued dietary modifications and physical activity, making it a viable option for patients switching from other GLP-1 treatments.
EverydayMeds Ordering Process For Wegovy Maintenance Switch
Switching to Wegovy maintenance through EverydayMeds begins with our streamlined 3-minute online clinical assessment, designed to capture your current medication history and treatment goals. Our prescribers review applications within 3 working days (or 24 hours with express service), ensuring safe transition protocols are followed when switching from alternative GLP-1 medications. Once approved, your Wegovy maintenance supply ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transport. This process eliminates treatment gaps that could disrupt your weight management progress, while our pharmacy team coordinates with your existing prescriptions to ensure seamless medication transitions. All orders are processed through our GPhC-registered facility (#9012878), meeting UK regulatory standards for prescription-only medicine supply.
Storage And Practical Considerations For Wegovy Maintenance Treatment
Wegovy maintenance pens require refrigeration at 2-8°C before first use, though they can be stored at room temperature below 30°C for up to 6 weeks once removed from refrigeration. This storage flexibility provides an advantage for patients switching from Mounjaro, which allows only 21 days at room temperature, making Wegovy more suitable for travel or variable storage situations. The FlexTouch pen design delivers consistent 2.4mg doses with simple injection technique, administered once weekly on the same day each week. Patients switching to maintenance should be aware that dose escalation cannot be skipped if treatment is interrupted, so maintaining consistent supply through our bundle options helps avoid restarting the escalation schedule. Each pen provides 4 doses, requiring monthly replacement for continuous maintenance treatment.
Why Patients Switch To Wegovy For Maintenance Weight Management
Clinical experience shows patients switch to Wegovy maintenance for various reasons including cost optimisation, side effect management, and medication availability concerns. Some patients find Wegovy's side effect profile more tolerable during long-term maintenance, while others appreciate the storage flexibility and established clinical evidence base. The STEP trial programme specifically studied maintenance dosing scenarios, providing robust data about long-term outcomes that some patients find reassuring when making treatment decisions.
Switching during maintenance phases also allows patients to evaluate whether different GLP-1 medications provide varying appetite control or satiety effects at therapeutic doses. EverydayMeds supports these transitions by stocking multiple GLP-1 options, allowing prescribers to recommend switches based on individual patient responses rather than medication availability constraints. This flexibility proves particularly valuable for patients seeking optimal long-term weight management outcomes through personalised treatment approaches.
Order Your Wegovy Maintenance Supply With Confidence
Ready to explore whether Wegovy maintenance dosing supports your weight management goals? Complete our clinical assessment today and discover potential savings through our Switch & Save pricing structure. New customers use code FIRST40 at checkout, while returning patients apply DOSE25 to access our competitive maintenance pricing starting from £209.99 per pen. Our Ultimate Stability Trio ensures three months of uninterrupted supply for £649.99, supporting consistent treatment that clinical evidence shows is essential for sustained benefits. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your assessment and take the next step in your weight management journey. Remember, Wegovy is a prescription-only medicine that should be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
